Investigational Site Number 840159
Knoxville, Tennessee 37920
0 studies enrolling now · 2 studies all time
What they study most
Dyslipidemia, Type 2 Diabetes Mellitus
Studies at this site
- Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes Mellitus on Basal Plus Mealtime Insulin — Completed
- Efficacy and Safety of Alirocumab Versus Usual Care on Top of Maximally Tolerated Statin Therapy in Patients With Type 2 Diabetes and Mixed Dyslipidemia (ODYSSEY DM-Dyslipidemia) — Completed